About
Curoverse provides genomic and biomedical computing solutions that help manage, process, analyze, and share massive biomedical data sets. Their core product is Arvados, an open-source computing system for data management and processing, which serves bioinformaticians, researchers, IT teams, and clinical testing labs. Arvados enables flexible deployment on-premise or in the cloud, ensuring data and software control while facilitating collaboration.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Curoverse do?
Curoverse provides genomic and biomedical computing solutions that help manage, process, analyze, and share massive biomedical data sets. Their core product is Arvados, an open-source computing system for data management and processing, which serves bioinformaticians, researchers, IT teams, and clinical testing labs. Arvados enables flexible deployment on-premise or in the cloud, ensuring data and software control while facilitating collaboration.
How much funding has Curoverse raised?
Curoverse has raised a total of $3M in funding. The most recent round on record is Later Stage VC.
When was Curoverse founded?
Curoverse was founded in 2010.
What is Curoverse's current status?
Curoverse's current operating status is: Acquired.